Kite Pharma, Inc., IPO Research Information

Kite Pharma, Inc., IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Kite Pharma, Inc.,, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Kite Pharma, Inc.,	KITE - NASDAQ	$15.00-$16.00	$17.00	$25.45	7.5 million	6/20/2014
Underwriter(s): Jefferies, Credit Suisse, Cowen and Co.
Co-Manager(s): Stifel
Industry: Health Care
Filing(s): Filed 2014-05-19 Terms Added 2014-06-11 Terms Added 2014-06-19

Kite Pharma, Inc., Quote & Chart - Click for current quote - KITE

About Kite Pharma, Inc., (adapted from Kite Pharma, Inc., prospectus):
They are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells.

This description is adapted from Kite Pharma prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Kite Pharma "KITE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.